Clinical relevance of microsatellite instability in colorectal cancer

Journal of Clinical Oncology

Volumn 28, Issue 20, 2010, Pages 3380-3387

  De La Chapelle, Albert ^a   Hampel, Heather ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CHROMOSOMAL INSTABILITY; COLORECTAL ADENOMA; COLORECTAL CANCER; GENE MUTATION; GENETIC MARKER; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; ARTICLE; COLORECTAL TUMOR; GENETICS; MISMATCH REPAIR; POLYMERASE CHAIN REACTION;

COLORECTAL NEOPLASMS; DNA MISMATCH REPAIR; GENETIC MARKERS; HUMANS; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 77954720070     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.27.0652     Document Type: Review

References (59)

1. Pasche B, Luo Y, Rao PH, et al: Type I transforming growth factor β receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res 58:2727-2732, 1998 (Pubitemid 28311899)
2. Markowitz S, Wang J, Myeroff L, et al: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338, 1995
3. Rampino N, Yamamoto H, Ionov Y, et al: Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275:967-969, 1997 (Pubitemid 27087710)
4. Pyatt R, Chadwick RB, Johnson CK, et al: Polymorphic variation at the BAT-25 and BAT-26 loci in individuals of African origin: Implications for microsatellite instability testing. Am J Pathol 155:349-353, 1999 (Pubitemid 29370385)
5. Hienonen T, Sammalkorpi H, Enholm S, et al: Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers. Cancer Res 65:4607-4612, 2005
6. Sammalkorpi H, Alhopuro P, Lehtonen R, et al: Background mutation frequency in microsatellite-unstable colorectal cancer. Cancer Res 67:5691-5698, 2007 (Pubitemid 46985001)
7. Boland CR, Thibodeau SN, Hamilton SR, et al: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257, 1998 (Pubitemid 28521189)
8. Hoang J-M, Cottu PH, Thuille B, et al: BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 57:300-303, 1997 (Pubitemid 27036610)
9. Zhou X-P, Hoang J-M, Cottu P, et al: Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors. Oncogene 15:1713-1718, 1997 (Pubitemid 27466711)
10. Suraweera N, Duval A, Reperant M, et al: Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 123:1804-1811, 2002
11. Mead LJ, Jenkins MA, Young J, et al: Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes. Clin Cancer Res 13:2865-2869, 2007 (Pubitemid 46849559)
12. Ahrendt SA, Decker PA, Doffek K, et al: Microsatellite instability at selected tetranucleotide repeats is associated with p53 mutations in nonsmall cell lung cancer. Cancer Res 60:2488-2491, 2000 (Pubitemid 30262442)
13. Palomaki GE, McClain MR, Melillo S, et al: EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genetics in Medicine 11:42-65, 2009
14. Plaschke J, Engel C, Kruger S, et al: Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: The German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 22:4486-4494, 2004 (Pubitemid 41185114)
15. Murphy KM, Zhang S, Geiger T, et al: Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn 8:305-311, 2006 (Pubitemid 44063806)
16. Aaltonen LA, Salovaara R, Kristo P, et al: Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 38:1481-1487, 1998 (Pubitemid 28226275)
17. Salovaara R, Loukola A, Kristo P, et al: Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 18:2193-2200, 2000 (Pubitemid 30350210)
18. Samowitz WS, Curtin K, Lin HH, et al: The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 121:830-838, 2001 (Pubitemid 32959394)
19. Hampel H, Frankel WL, Martin E, et al: Feasibility of screening for Lynch syndrome among colorectal cancer patients. J Clin Oncol 26:5783-5788, 2008
20. Aaltonen LA, Peltomäki P, Mecklin J-P, et al: Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 54:1645-1648, 1994 (Pubitemid 24116162)
21. Mueller J, Gazzoli I, Bandipalliam P, et al: Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Res 69:7053-7061, 2009
22. Hampel H, Frankel WL, Martin E, et al: Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352:1851-1860, 2005
23. Graham T, Halford S, Page KM, et al: Most low-level microsatellite instability in colorectal cancers can be explained without an elevated slippage rate. J Pathol 215:204-210, 2008 (Pubitemid 351786039)
24. Laiho P, Launonen V, Lahermo P, et al: Low-level microsatellite instability in mot colorectal carcinomas. Cancer Res 62:1166-1170, 2002 (Pubitemid 34160304)
25. Halford S, Sasieni P, Rowan A, et al: Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait. Cancer Res 62:53-57, 2002 (Pubitemid 34073985)
26. Kohonen-Corish MR, Daniel JJ, Chan C, et al: Low microsatellite instability is associated with poor prognosis in stage C colon cancer. J Clin Oncol 23:2318-2324, 2005 (Pubitemid 46218724)
27. Kim YH, Min BH, Choi HK, et al: Sporadic colorectal carcinomas with low-level microsatellite instability in Korea: Do they form a distinct subgroup with distinguished clinicopathological features? J Surg Oncol 99:351-355, 2009
28. Wright CM, Dent OF, Newland RC, et al: Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma. Gut 54:103-108, 2005 (Pubitemid 40007227)
29. + tumor cells. Cell 75:1227-1236, 1993
30. Lynch HT, Lynch PM, Lanspa SJ, et al: Review of the Lynch syndrome: History, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76:1-18, 2009
31. Pinol V, Castells A, Andreu M, et al: Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 293:1986-1994, 2005
32. Boland CR, Koi M, Chang DK, et al: The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: From bench to bedside. Fam Cancer 7:41-52, 2008
33. Kane MF, Loda M, Gaida GM, et al: Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57:808-811, 1997, et al: 1997
34. Cunningham JM, Christensen ER, Tester DJ, et al: Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. 58:3455-3460, 1998
35. Herman JG, Umar A, Polyak K, et al: Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 95:6870-6875, 1998 (Pubitemid 28278073)
36. Bessa X, Balleste B, Andreu M, et al: A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening. Clin Gastrenterol Hepatol 6:206-214, 2008
37. Kuismanen SA, Holmberg MT, Salovaara R, et al: Genetic and epigenetic modification accounts for a major share of microsatellite-unstable colorectal cancers. Am J Pathol 156:1773-1779, 2000 (Pubitemid 30646714)
38. Loukola A, Salovaara R, Kristo P, et al: Microsatllite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer. Am J Pathol 155:1849-1853, 1999
39. Watanabe T, Kanazawa T, Kazama Y, et al: Microsatellite instability in adenoma as a possible marker to identify HNPCC patients. Am J Gastorenterol 101:204, 2006 (Pubitemid 43381736)
40. Velayos FS, Allen BA, Conrad PG, et al: Low rate of microsatellite instability in young patients with adenomas: Reassessing the Bethesda guidelines. Am J Gastroenterol 100:1143-1149, 2005 (Pubitemid 40769054)
41. Koh DC, Luchtefeld MA, Kim DG, et al: Microsatellite instability and MLH1 hypermethylation - incidence and significance n colorectal polyps in young patients. Colorectal Disease 9:521-526, 2007 (Pubitemid 46958542)
42. Müller A, Beckmann C, Westphal G, et al: Prevalence of the mismatch-repair-deficient phenotype in colonic adenomas arising in HNPCC patients: Results of a 5-year follow-up study. Int J Colorectal Dis 21:632-641, 2006 (Pubitemid 44446062)
43. Ferreira S, Claro I, Lage P, et al: Colorectal adenomas in young patients: Microsatellite instability is not a useful marker to detect new cases of Lynch syndrome. Dis Colon Rectum 51:909-915, 2008
44. Pino MS, Mino-Kenudson M, Wildemore BM, et al: Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas. J Mol Diagn 11:238-247, 2009
45. Ferreira AM, Westers H, Sousa S, et al: Mononucleotide precedes dinucleotide repeat instability during colorectal tumor development in Lynch syndrome patients. J Pathol 219:96-102, 2009
46. Popat S, Hubner R, Houlston RS: Systematic review of microsatellite instability and colorectal cancer prognosis. J Clinl Oncol 23:609-617, 2005
47. Jover, R, Zapater P, Castells A, et al: The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer 45:365-373, 2009
48. Kim GP, Colangelo LH, Wieand S, et al: Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: A National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol 25:767-772, 2007 (Pubitemid 350002875)
49. Boland CR: Clinical uses of microsatellite instability testing in colorectal cancer: An ongoing challenge. J Clin Oncol 25:754-756, 2007
50. Walther A, Houlston R, Tomlinson I: Association between chromosomal instability and prognosis in colorectal cancer: A meta-analysis. Gut 57:941-950, 2008 (Pubitemid 351919529)
51. Elsaleh H, Joseph D, Grieu F, et al: Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 355:1745-1750, 2000 (Pubitemid 30265078)
52. Hemminki A, Mecklin JP, Järvinen H, et al: Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 119:921-928, 2000
53. Elsaleh H, Powell B, Soontrapornchai P, et al: p53 gene mutation, microsatellite instability and adjuvant chemotherapy: Impact on survival of 388 patients with Dukes' C colon carcinoma. Oncology 58:52-59, 2000 (Pubitemid 30045310)
54. Tajima A, Hess MT, Cabrera BL, et al: The mismatch repair complex hMutS alpha recognizes 5-fluroruracil-modified DNA: Implications for chemosensitivity and resistance. Gastroenterology 127:1678-1684, 2004 (Pubitemid 39575846)
55. Arnold CM, Goel A, Boland CR: Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. Int J Cancer 106:66-73, 2003 (Pubitemid 36750389)
56. Carethers JM, Chauhan DP, Fink D, et al: Mismatch repair proficiency and in vitro response to 5-fluorouricil. Gastroenterology 117:123-131, 1999 (Pubitemid 29297628)
57. Meyers M, Wagner MW, Hwang HS, et al: Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses. Cancer Res 61:5193-5201, 2001 (Pubitemid 32681553)
58. Ribic CM, Sargent DJ, Moore MJ, et al: Tumor microsatellite-instability status as a predictor of benefit from Fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349:247-257, 2003 (Pubitemid 36859476)
59. Des Guetz G, Schischmanoff O, Nocalas P, et al: Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. Euro J Cancer 45:1890-1896, 2009